Skip to main content


Fig. 4 | Cell & Bioscience

Fig. 4

From: Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles

Fig. 4

In vivo effect of ferulic acid (FA) and aspirin (ASP) c-SLNs on MIA PaCa-2 xenograft SCID mice. a Flow chart representation of experimental design for in vivo studies. b Body weight variations of xenograft SCID mice during the FA and ASP c-SLNs treatment period. Average body weight transitions of mice over the 35 days treatment period. c Average tumor growth of pancreatic cancer cells MIA PaCa-2 over a period of 35 d after treatment. FA and ASP c-SLNs were administered via oral gavage for 35 days. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple comparison test post hoc analysis

Back to article page